It accounts for ~75% of renal cell carcinoma (RCC) cases [2] and is characterized by distinct genetic abnormalities, most notably the loss of function of the von Hippel-Lindau (VHL) tumor suppressor gene [3, 4]. This evidence concerns the gene VHL and renal cell carcinoma.